Heteroactivator effects on the coupling and spin state equilibrium of CYP2C9

被引:31
作者
Locuson, Charles W.
Gannett, Peter M.
Tracy, Timothy S. [1 ]
机构
[1] Univ Minnesota, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA
[2] W Virginia Univ, Dept Basic Pharmaceut Sci, Morgantown, WV 26506 USA
关键词
cytochrome P450; P450; CYP; heteroactivation; coupling; shunting; atypical kinetics;
D O I
10.1016/j.abb.2006.02.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cytochromes P450 are capable of oxidizing a variety of xenobiotics. Binding of a small molecule heteroactivator to a P450 can alter the coupling of substrate oxidation during P450 catalysis, but the degree to which coupling or shunting via one of the three catalytic cycle branch points is linked to the heteroactivator-modified position of bound substrate is unknown. Using reconstituted CYP2C9, stoichiometric measurements were gathered with three substrates and two classes of heteroactivators to further understand the mechanisms involved in heteroactivation. Heteroactivation of P450 metabolism appeared to involve, but not require, changes in coupling and that increased uncoupling to a specific byproduct like H2O2 does not necessarily correlate to the degree of coupling. In addition, spectroscopy demonstrated that every heteroactivator tested influenced the spin equilibrium of the heme iron even in the presence of saturating substrate suggesting that both substrate proximity and the ability to desolvate the heme can be involved in heteroactivation. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:115 / 129
页数:15
相关论文
共 44 条
[1]   METABOLIC SWITCHING IN CYTOCHROME-P-450CAM - DEUTERIUM-ISOTOPE EFFECTS ON REGIOSPECIFICITY AND THE MONOOXYGENASE OXIDASE RATIO [J].
ATKINS, WM ;
SLIGAR, SG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1987, 109 (12) :3754-3760
[2]   Non-Michaelis-Menten kinetics in cytochrome P450-catalyzed reactions [J].
Atkins, WM .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2005, 45 :291-310
[3]  
BACKES WL, 1989, J BIOL CHEM, V264, P6252
[4]   Identification of the binding site on cytochrome P450 2B4 for cytochrome b5 and cytochrome P450 reductase [J].
Bridges, A ;
Gruenke, L ;
Chang, YT ;
Vakser, IA ;
Loew, G ;
Waskell, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (27) :17036-17049
[5]  
CASE DA, 2004, AMBER, V8
[6]   Rabbit CYP4B1 engineered for high-level expression in Escherichia coli:: ligand stabilization and processing of the N-terminus and heme prosthetic group [J].
Cheesman, MJ ;
Baer, BR ;
Zheng, YM ;
Gillam, EMJ ;
Rettie, AE .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2003, 416 (01) :17-24
[7]  
*CT GAUSS INC, 2004, GAUSS 03 REV B 01
[8]   Crystal structures of ligand complexes of P450eryF exhibiting homotropic cooperativity [J].
Cupp-Vickery, J ;
Anderson, R ;
Hatziris, Z .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3050-3055
[9]   Pyrene-pyrene complexes at the active site of cytochrome P450 3A4: Evidence for a multiple substrate binding site [J].
Dabrowski, MJ ;
Schrag, ML ;
Wienkers, LC ;
Atkins, WM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (40) :11866-11867
[10]  
ESTABROOK RW, 1979, ACTA BIOL MED GER, V38, P423